ResearcherChina Pharmaceutical UniversityNo recent work listed
Yannan Xia
Matched on OpenAlex author ID A5040810775. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 2 papers
Papers 2
- Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and G… Co-author DOI 10.1016/j.ejphar.2023.176157↗
- Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models. Co-author DOI 10.1038/s41420-023-01359-4↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yumeng Wang · 2 shared papers, 2023 · strength 0.40
- Paper Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that … DOI 10.1016/j.ejphar.2023.176157↗
- Paper Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in precli… DOI 10.1038/s41420-023-01359-4↗
- Yuanyuan Jiang · 2 shared papers, 2023 · strength 0.40
- Paper Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that … DOI 10.1016/j.ejphar.2023.176157↗
- Paper Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in precli… DOI 10.1038/s41420-023-01359-4↗
- Shengtao Yuan · 1 shared paper, 2023 · strength 0.20
- Li Sun · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.